PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2004.01963.x200419111159-1172Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis CO. S. Lin, E. B. Keeffe, G. D. Sanders, D. K. Owenshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2004.01963.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2004.01963.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2004.01963.x/fullpdf
Journal of Hepatology10.1016/s0168-8278(99)80412-7199931255-258Cost-effectiveness of treatment for chronic hepatitis CRaymond S. Koffhttps://api.elsevier.com/content/article/PII:S0168827899804127?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827899804127?httpAccept=text/plain
Clinical and Molecular Hepatology10.3350/cmh.2021.01932022282164-173Cost-effectiveness of chronic hepatitis C screening and treatmentHye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kimhttp://e-cmh.org/upload/pdf/cmh-2021-0193.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2021.0193, http://e-cmh.org/upload/pdf/cmh-2021-0193.pdf
Journal of Viral Hepatitis10.1111/j.1365-2893.2008.01008.x2008???-???The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysisA. J. Sutton, W. J. Edmunds, M. J. Sweeting, O. N. Gillhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2008.01008.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2008.01008.x/fullpdf
Medicina10.3390/medicina4612011720104612835Cost-effectiveness and cost-utility of the treatment of chronic hepatitis B with peginterferon alfa-2a, interferon alfa, and lamivudine in LithuaniaGiedrius Vanagas, Žilvinas Padaiga, Aušra Mickevičienėhttps://www.mdpi.com/1648-9144/46/12/835/pdf
Value in Health10.1016/s1098-3015(11)70512-5200032124PHV20: COST-EFFECTIVENESS ANALYSIS OF LAMIVUDINE TREATMENT IN CHRONIC HEPATITIS BYC Yeh, AK Biddle, AG Hartzemahttps://api.elsevier.com/content/article/PII:S1098301511705125?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301511705125?httpAccept=text/plain
Liver International10.1111/j.1478-3231.2011.02559.x20113181179-1190Cost effectiveness of screening immigrants for hepatitis BWilliam W. L. Wong, Gloria Woo, E. Jenny Heathcote, Murray Krahnhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-3231.2011.02559.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2011.02559.x/fullpdf
Journal of Viral Hepatitis10.1111/jvh.1211120132012847-857All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analysesL. M. Hagan, Z. Yang, M. Ehteshami, R. F. Schinazihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12111, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12111, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12111/fullpdf
Value in Health10.1016/j.jval.2014.08.24782014177A670The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment-Experienced Chronic Hepatitis C Patients in TurkeyO. Ozdemirhttps://api.elsevier.com/content/article/PII:S1098301514044088?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301514044088?httpAccept=text/plain
Value in Health10.1046/j.1524-4733.2001.40202-179.x200142136PID21: THE COST-EFFECTIVENESS ANALYSIS OF LAMIVUDINE IN THE TREATMENT OF CHRONIC HEPATITIS B IN POLANDE Orlewskahttps://api.elsevier.com/content/article/PII:S1098301511713365?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301511713365?httpAccept=text/plain